4.5 Article

Physico-chemical properties of aluminum adjuvants in vaccines: Implications for toxicological evaluation

Journal

VACCINE
Volume 40, Issue 33, Pages 4881-4888

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2022.06.064

Keywords

Aluminum adjuvants; Vaccines; Particle size; Zeta potential; Shape

Funding

  1. National Research Agency [ANR-19-CE17-0007, R19162DD]
  2. E3M
  3. CMSRI
  4. iFL
  5. ANR
  6. E3M association
  7. Agence Nationale de la Recherche (ANR) [ANR-19-CE17-0007] Funding Source: Agence Nationale de la Recherche (ANR)

Ask authors/readers for more resources

This study evaluated the physicochemical properties of aluminum adjuvants and their impact on biological effects. The results showed that different aluminum adjuvants have distinct shapes, sizes, and charges, and dilution and protein adsorption can affect the size of aggregates. Therefore, a comprehensive evaluation of the physicochemical properties of aluminum particles is important before conducting any biological or toxicological studies.
Aluminum salts have been used as adjuvants in human vaccines since 1932. The most used adjuvants are Al oxyhydroxide (AlOOH) and Al hydroxyphosphate (AlOHPO4). Al adjuvants have different physicochemical properties. The differences in these properties are not well documented and not considered by the Food and Drug Administration (FDA), though they can largely influence biological effects of the adjuvants which are particulate components. In this study, different physico-chemical properties including the shape, size and charge of particles have been evaluated under different conditions in three Al adjuvants containing-vaccines and two corresponding commercial adjuvants suspensions. The results showed that the two Al adjuvants have different shapes, sizes and charges but both form aggregates. In addition, a clear effect of dilution on the size of the aggregates was observed. Moreover, different sizes of Al particles were measured for both Al oxyhydroxide adjuvant alone or in the vaccine, at identical concentrations, displaying the impact of adsorbed proteins on the size of aggregates in the case of the vaccine. Taken together, this paper suggests the importance to evaluate, before any biological and especially toxicological impact study, the whole physico-chemical properties of Al particle without restricting to the sole evaluation of the injected concentration. Furthermore, any modification of these mentioned parameters during manipulation, before animal or cell exposure, should be considered. In a more global way, the fixed ''safe dose of Al adjuvants should be specific for each type of Al adjuvant independently or for a mix of the two compounds, due to their different properties. (c) 2022 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available